Aprameya Engineering (NSE:APRAMEYA) EBIT: ₹109.3 Mil (TTM As of Mar. 2026)


NSE:APRAMEYA Aprameya Engineering Ltd NSE:APRAMEYA
43 GF Score
Price ₹151.00
! 6 Warning Signs
View Full Analysis

What is Aprameya Engineering EBIT?

Aprameya Engineering NSE:APRAMEYA -1.15% 43 EBIT is ₹109.3 Mil as of Mar. 2026. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 43/100. The stock has 6 warning signs investors should review.

Aprameya Engineering's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹109.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹109.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aprameya Engineering's annualized ROC % for the quarter that ended in Mar. 2026 was 8.82%. Aprameya Engineering's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 14.46%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Aprameya Engineering's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.81%.

Aprameya Engineering  (NSE:APRAMEYA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aprameya Engineering's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=104.427 * ( 1 - 29.63% )/( (950.274 + 716.405)/ 2 )
=73.4852799/833.3395
=8.82 %

where

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1439.61 - 487.425 - ( 1.911 - max(0, 734.34 - 1364.584+1.911))
=950.274

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=822.682 - 31.939 - ( 74.338 - max(0, 104.968 - 732.965+74.338))
=716.405

Note: The Operating Income data used here is one times the annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Aprameya Engineering's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=109.304/( ( (20.545 + max(871.799, 0)) + (12.773 + max(607.011, 0)) )/ 2 )
=109.304/( ( 892.344 + 619.784 )/ 2 )
=109.304/756.064
=14.46 %

where Working Capital is:

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1191.241 + 71.752 + 99.222) - (487.425 + 0 + 2.991)
=871.799

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(555.198 + 26.861 + 76.483) - (31.939 + 0 + 19.592)
=607.011

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aprameya Engineering's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=109.304/2872.062
=3.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprameya Engineering EBIT Related Terms

Aprameya Engineering EBIT Historical Data

* Premium members only.

The historical data trend for Aprameya Engineering's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprameya Engineering EBIT Chart

Aprameya Engineering Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 249.34 88.65 63.00 248.99 109.30

Aprameya Engineering Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT Get a 7-Day Free Trial 249.34 88.65 63.00 248.99 109.30

NSE:APRAMEYA vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Aprameya Engineering's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aprameya Engineering EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aprameya Engineering's EV-to-EBIT falls into.


NSE:APRAMEYA
43GF Score
Aprameya Engineering Ltd NSE:APRAMEYA
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aprameya Engineering EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹109.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹109.3 Mil mean?
Aprameya Engineering (NSE:APRAMEYA) has a EBIT of ₹109.3 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aprameya Engineering.
Is Aprameya Engineering's EBIT too high?
Aprameya Engineering's current EBIT is ₹109.3 Mil. Overall, Aprameya Engineering has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's EBIT compare to ISRG and BDX?
Aprameya Engineering's EBIT of ₹109.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aprameya Engineering. Aprameya Engineering's current EBIT is ₹109.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current EBIT of ₹109.3 Mil. The current EBIT is ₹109.3 Mil. Aprameya Engineering's overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current EBIT is ₹109.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprameya Engineering Business Description

Address 908, 9th Floor, Venus Atlantis Corporate Park, Anandnagar, Prahladnagar, Ahmedabad, GJ, IND, 380015
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
43GF Score

Get the complete analysis for NSE:APRAMEYA

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹151.00
Price